(MedPage Today) — Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival (PFS) in some patients with recurrent estrogen receptor (ER)-positive endometrial cancer, per a phase…
Source link : https://www.medpagetoday.com/meetingcoverage/sgo/114676
Author :
Publish date : 2025-03-16 19:53:00
Copyright for syndicated content belongs to the linked Source.
